Addex Therapeutics (ADXN) Operating Expenses (2018 - 2026)
Addex Therapeutics (ADXN) posted Operating Expenses of -$622562.8 for Q1 2026, down 109.61% sequentially from $6.5 million in Q4 2025, and up 17.36% YoY from -$530471.2 in Q1 2025.
Addex Therapeutics (ADXN) Operating Expenses (2018 - 2026) Analysis & Trends
Addex Therapeutics has reported Operating Expenses for 9 years, with the latest figure at -$622562.8 in Q1 2026.
- Quarterly Operating Expenses rose 17.36% year-over-year to -$622562.8 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (up 175.43% YoY) and the FY2025 annual result came in at $3.6 million, changed 0.15% from the prior year.
- Operating Expenses slipped to -$622562.8 in Q1 2026 per ADXN's latest filing, from $6.5 million in the prior quarter.
- Over five years, Operating Expenses peaked at $6.5 million in Q4 2025 and troughed at -$15.2 million in Q4 2022.
- A 5-year average of -$2.5 million and a median of -$1.1 million in 2023 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2025: Operating Expenses sank 44.46% in 2022, then soared 345.67% in 2025.
- Over 5 years, Operating Expenses stood at -$15.2 million in 2022, then soared by 80.2% to -$3.0 million in 2023, then increased by 12.46% to -$2.6 million in 2024, then jumped by 345.67% to $6.5 million in 2025, then plunged by 109.61% to -$622562.8 in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered -$622562.8, $6.5 million, and -$932300.4 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.24 Bn | 131.39 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 86.01 Bn | 78.02 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 65.61 Bn | 60.42 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 56.92 Bn | 51.78 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 27.77 Bn | 9.38 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 541.02 Mn |
| 10 | Addex Therapeutics | 511.09 Mn | 511.09 Mn | - | -622,562.77 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -622,562.77 |
| Dec 31, 2025 | 6.48 Mn |
| Sep 30, 2025 | -932,300.42 |
| Jun 30, 2025 | -929,197.34 |
| Mar 31, 2025 | -753,346.20 |
| Dec 31, 2024 | -2.64 Mn |
| Sep 30, 2024 | -785,491.12 |
| Jun 30, 2024 | -1.12 Mn |
| Mar 31, 2024 | -1.17 Mn |
| Dec 31, 2023 | -3.01 Mn |
| Sep 30, 2023 | -1.22 Mn |
| Jun 30, 2023 | -1.14 Mn |
| Mar 31, 2023 | -940,290.34 |
| Dec 31, 2022 | -15.22 Mn |
| Sep 30, 2022 | -4.75 Mn |
| Jun 30, 2022 | -7.56 Mn |
| Mar 31, 2022 | -6.50 Mn |
| Dec 31, 2021 | -13.93 Mn |
| Sep 30, 2021 | -4.72 Mn |
| Jun 30, 2021 | -6.12 Mn |